Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTAFR known ✓ | P25105 | 1/20 | 0.36 |
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.36 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.36 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.36 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.36 |
| ▸ | PLA2G2C | Q5R387 | 8/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CASP2 | P42575 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.37 |
| ▸ | RAD52 | P43351 | 1/20 | 0.37 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.37 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9576021 | 0.95 | PLA2G2C (0.43) | PLA2G2CMEN1MAPTMAPK1CASP2 | |
| Hydrochloric Acid SCHEMBL9576018 | 0.95 | PLA2G2C (0.43) | PLA2G2CMEN1MAPTMAPK1CASP2 | |
| Hydrochloric Acid SCHEMBL9576065 | 0.87 | PLA2G2C (0.40) | PLA2G2CPTAFRACHE | |
| Hydrochloric Acid SCHEMBL9576068 | 0.87 | PLA2G2C (0.40) | PLA2G2CPTAFRACHE | |
| Bromide SCHEMBL9575795 | 0.81 | AKT1 (0.47) | KMT2ASMN1; SMN2RAD52ABCB11ESR1 | |
| Bromide SCHEMBL9575791 | 0.81 | AKT1 (0.47) | KMT2ASMN1; SMN2RAD52ABCB11ESR1 | |
| Bromide SCHEMBL9575784 | 0.81 | AKT1 (0.47) | KMT2ASMN1; SMN2RAD52ABCB11ESR1 | |
| Bromide SCHEMBL9575968 | 0.79 | EPHX1 (0.39) | PLA2G2CKMT2ASMN1; SMN2RAD52CHRM2 | |
| Bromide SCHEMBL9575963 | 0.79 | EPHX1 (0.39) | PLA2G2CKMT2ASMN1; SMN2RAD52CHRM2 | |
| Bromide SCHEMBL9575965 | 0.79 | EPHX1 (0.39) | PLA2G2CKMT2ASMN1; SMN2RAD52CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5187293-A | Blood platelet activating factor inhibitors | HOFFMANN-LA ROCHE INC. (US) | 1993-02-16 | — | — | US | disclosed |
| US-4731373-A | BLOOD PLATELET ACTIVATING FACTOR | HOFFMAN-LA ROCHE INC. (US) | 1988-03-15 | — | — | US | disclosed |